We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 326

Patent term extensions and regulatory exclusivities for pharmaceuticals in Asia and South America

  • Morrison & Foerster LLP
  • -
  • Argentina, Brazil, Chile, China, Hong Kong, Japan, Malaysia, Mexico, Philippines, South Korea, Thailand, USA, Vietnam
  • -
  • June 27 2012

Patent protection for pharmaceutical products has an impact on the pharmaceutical market and innovation

The keys to success in patent litigation

  • LexField Law Offices
  • -
  • China
  • -
  • August 27 2013

The National Intellectual Property Strategy means that foreign patentees must adapt to a new litigation landscape when enforcing their patents in

Patent procurement and enforcement in China: a field guide

  • Morrison & Foerster LLP
  • -
  • China
  • -
  • November 18 2011

It is difficult to read the world news today and not come across an article (or three) that discusses the increasingly important role that China plays in the world’s economy

Compulsory patent licensing in China

  • Morrison & Foerster LLP
  • -
  • China
  • -
  • January 16 2013

Recent years have seen a growing trend among developing countries such as Thailand, Malaysia, Indonesia, India, and Brazil of enacting and utilizing

Pharmaceutical compulsory licences in emerging markets: necessity or threat?

  • CMS Cameron McKenna
  • -
  • China, India
  • -
  • August 27 2013

A compulsory licence provides that the owner of a patent licenses the use of their rights in return for payment either set by law or determined

Overview of patent-statutory subject matter in biotechnology

  • CCPIT Patent & Trademark Law Office
  • -
  • China, European Union, Japan, USA
  • -
  • April 8 2013

With the advent of biotechnology, the human community stands on the threshold of an extraordinary revolution having profound

A second look at IDC investigation case in China

  • Tian Yuan Law Firm
  • -
  • China
  • -
  • June 8 2014

Following numerous high-profile cases concluded by the National Development Reform Commission ("NDRC") in 2013 against cartel and RPMs, abuse of

Utility model patents in China

  • Tsai Lee & Chen
  • -
  • China
  • -
  • July 18 2013

Inventions, utility models and designs are the three categories of patent protection available in China. An applicant may apply for an invention

A discussion of patent infringement issues through the analysis of a hypothetical case

  • Kangxin Partners PC
  • -
  • China
  • -
  • December 5 2013

The case discussed in this article is not a real case, and the patent at issue and the alleged infringing product involved in the case are

China’s Patent Re-Examination Board says pharmaceutical salts not patentable over pure compounds

  • Greenberg Traurig LLP
  • -
  • China
  • -
  • August 14 2013

In July 2013, the Patent Re-Examination Board of China's State Intellectual Property Office invalidated the U.S. biotech company, Gilead Sciences'